Registration

VALENTE & ASSOCIATES for THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

In opposition to DEA's classification of Kratom as a Schedule I controlled substance

LobbyistCovered position, as disclosed
MARK WILLIAM RODGERS New Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce
J DANIEL WALSH New Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner

Government Issues GOV

In opposition to DEA's classification of Kratom as a Schedule I controlled substance

LobbyistCovered position, as disclosed
MARK WILLIAM RODGERS New Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce
J DANIEL WALSH New Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner

Health Issues HCR

In opposition to DEA's classification of Kratom as a Schedule I controlled substance

LobbyistCovered position, as disclosed
MARK WILLIAM RODGERS New Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce
J DANIEL WALSH New Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.